VEGFA and systemic sclerosis: The pooled analysis showed that SSc patients with diffuse disease had significantly higher VEGF concentrations than those with localized disease (SMD=0.30, 95% CI 0.01 to 0.59, p=0.046; I2 = 60.3%, p=0.005; Figure 4).